Skip to main content

Advertisement

SpringerLink
Log in

Readmissions Following Pancreaticoduodenectomy for Pancreas Cancer: A Population-Based Appraisal

  • Healthcare Policy and Outcomes
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Procedure complexity and volume–outcome relationships have led to increased regionalization of pancreaticoduodenectomy (PD) for pancreas cancer. Knowledge regarding outcomes after PD comes from single-institutional series, which may be limited if a significant number of patients follow up at other hospitals. Thus, readmission data may be underreported. This study utilizes a population-based data set to examine readmission data following PD. California Cancer Registry (1994–2003) was linked to the California’s Office of Statewide Health Planning and Development (OSHPD) database; patients with pancreatic adenocarcinoma who had undergone PD, excluding perioperative (30-day) mortality, were identified. All hospital readmissions within 1 year following PD were analyzed with respect to timing, location, and reason for readmission. Our cohort included 2,023 patients who underwent PD for pancreas cancer. Fifty-nine percent were readmitted within 1 year following PD and 47% were readmitted to a secondary hospital. Readmission was associated with worse median survival compared with those not readmitted (10.5 versus 22 months, p < 0.0001). Multivariate analysis revealed that increasing T-stage, age, and comorbidities were associated with increased likelihood of readmission. Diagnoses associated with high rates of readmission included progression of disease (24%), surgery-related complications (14%), and infection (13%). Diabetes (1.4%) and pain (1.5%) were associated with low rates of readmission. We found a readmission rate of 59%, which is much higher than previously reported by single institutional series. Concordantly, nearly half of patients readmitted were readmitted to a secondary hospital. Common reasons for readmission included progression of disease, surgical complications, and infection. These findings should assist in both anticipating and facilitating postoperative care as well as managing patient expectations. This study utilizes a novel population-based database to evaluate incidence, timing, location, and reasons for readmission within 1 year following pancreaticoduodenectomy. Fifty-nine percent of patients were readmitted within 1 year after pancreaticoduodenectomy and 47% were readmitted to a secondary hospital.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. www.cancer.org.

  2. Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 2006;10:1199–210; discussion 1210–1191.

    Article  PubMed  Google Scholar 

  3. Schniewind B, Bestmann B, Henne-Bruns D, Faendrich F, Kremer B, Kuechler T. Quality of life after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head. Br J Surg. 2006;93:1099–107.

    Article  PubMed  CAS  Google Scholar 

  4. Farnell MB, Pearson RK, Sarr MG, et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery. 2005;138:618–28; discussion 628–30.

    Article  PubMed  Google Scholar 

  5. Brennan MF, Kattan MW, Klimstra D, Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004;240:293–8.

    Article  PubMed  Google Scholar 

  6. Balcom JHt, Rattner DW, Warshaw AL, Chang Y, Fernandez-del Castillo C. Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg. 2001;136:391–8.

    Article  PubMed  Google Scholar 

  7. Schmidt CM, Powell ES, Yiannoutsos CT, et al. Pancreaticoduodenectomy: a 20-year experience in 516 patients. Arch Surg. 2004;139:718–25; discussion 725–717.

    Article  PubMed  Google Scholar 

  8. Raut CP, Tseng JF, Sun CC, et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg. 2007;246:52–60.

    Article  PubMed  Google Scholar 

  9. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg. 2004;91:586–94.

    Article  PubMed  CAS  Google Scholar 

  10. Grobmyer SR, Pieracci FM, Allen PJ, Brennan MF, Jaques DP. Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system. J Am Coll Surg. 2007;204:356–64.

    Article  PubMed  Google Scholar 

  11. De Oliveira ML, Winter JM, Schafer M, et al. Assessment of complications after pancreatic surgery: a novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg. 2006;244:931–7; discussion 937–9.

    Article  Google Scholar 

  12. Kazanjian KK, Hines OJ, Eibl G, Reber HA. Management of pancreatic fistulas after pancreaticoduodenectomy: results in 437 consecutive patients. Arch Surg. 2005;140:849–54; discussion 854–846.

    Article  PubMed  Google Scholar 

  13. Satoi S, Takai S, Matsui Y, et al. Less morbidity after pancreaticoduodenectomy of patients with pancreatic cancer. Pancreas. 2006;33:45–52.

    Article  PubMed  Google Scholar 

  14. Cameron JL, Riall TS, Coleman J, Belcher KA. One thousand consecutive pancreaticoduodenectomies. Ann Surg. 2006;244:10–5.

    Article  PubMed  Google Scholar 

  15. Bilimoria KY, Bentrem DJ, Ko CY, et al. Multimodality therapy for pancreatic cancer in the U.S.: utilization, outcomes, and the effect of hospital volume. Cancer. 2007;110:1227–34.

    Article  PubMed  Google Scholar 

  16. Birkmeyer JD, Sun Y, Wong SL, Stukel TA. Hospital volume and late survival after cancer surgery. Ann Surg. 2007;245:777–83.

    Article  PubMed  Google Scholar 

  17. Fong Y, Gonen M, Rubin D, Radzyner M, Brennan MF. Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg. 2005;242:540–4; discussion 544–7.

    PubMed  Google Scholar 

  18. van Geenen RC, van Gulik TM, Busch OR, de Wit LT, Obertop H, Gouma DJ. Readmissions after pancreatoduodenectomy. Br J Surg. 2001;88:1467–71.

    Article  PubMed  Google Scholar 

  19. Emick DM, Riall TS, Cameron JL, et al. Hospital readmission after pancreaticoduodenectomy. J Gastrointest Surg. 2006;10:1243–52; discussion 1252–1243.

    Article  PubMed  Google Scholar 

  20. www.ccrcal.org.

  21. www.oshpd.ca.gov.

  22. Perkins AJ, Kroenke K, Unutzer J, et al. Common comorbidity scales were similar in their ability to predict health care costs and mortality. J Clin Epidemiol. 2004;57:1040–8.

    Article  PubMed  Google Scholar 

  23. Brescia FJ. Palliative care in pancreatic cancer. Cancer Control. 2004;11:39–45.

    PubMed  Google Scholar 

  24. Nathan H, Pawlik TM. Limitations of claims and registry data in surgical oncology research. Ann Surg Oncol. 2008;15:415–23.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Greater Los Angeles VA Healthcare System, Los Angeles, CA, USA

    Irina Yermilov, Melinda A. Maggard, Clifford Y. Ko & James S. Tomlinson

  2. Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

    Irina Yermilov, Evan Sekeris, Sushma Jain, Melinda A. Maggard, Clifford Y. Ko & James S. Tomlinson

  3. Department of Surgery, Northwestern University, Chicago, IL, USA

    David Bentrem

  4. UCLA Surg-Onc, Box 951782, 54-139A CHS, Los Angeles, CA, 90095-1782, USA

    James S. Tomlinson

Authors
  1. Irina Yermilov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Bentrem
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Evan Sekeris
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sushma Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Melinda A. Maggard
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Clifford Y. Ko
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. James S. Tomlinson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James S. Tomlinson.

Electronic supplementary material

Below is the link to the electronic supplementary material.

(PDF 88 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yermilov, I., Bentrem, D., Sekeris, E. et al. Readmissions Following Pancreaticoduodenectomy for Pancreas Cancer: A Population-Based Appraisal. Ann Surg Oncol 16, 554–561 (2009). https://doi.org/10.1245/s10434-008-0178-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-008-0178-6

Keywords

Search

Navigation